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South Africa’s burden of disease due to sexually transmitted 
infections (STIs) is currently one of the largest in the world. 
It is estimated that there are now more than 5 million HIV 
infections in South Africa, and there has been a rapid rise 
in mortality due to HIV/AIDS over the last decade.1 The 
prevalence of other STIs is also high,2 and these STIs are a 
significant threat – both as a common cause of infertility and 
adverse pregnancy outcomes, and as infections that increase 
the risk of HIV transmission. Cervical cancer, which accounts 
for more female deaths than any other cancer in South 
Africa,3 also forms part of the STI burden, as it is caused by 
the sexually transmitted human papillomavirus (HPV). The 
prevention and treatment of STIs is therefore immensely 
important to public health in South Africa. It is also important 
that this disease burden be quantified and monitored.
Attempts to determine the total burden of disease 
attributable to STIs typically focus on ‘unsafe sex’ as the risk 
factor responsible for this disease burden.4,5 In the World 
Health Organization (WHO) comparative risk assessment 
(CRA) study,5 unsafe sex is defined as unprotected sex with a 
partner who has an STI, and the approach for this risk factor is 
therefore different from that for other risk factors, which have 
a single characteristic resulting in a poor health outcome. In 
the case of ‘unsafe sex’, the outcome itself contributes to the 
risk factor; STI transmission is the result of both unprotected 
sex and one partner already being infected. The latter depends 
as much on the population prevalence of the STI as on risky 
sexual behaviours and individual susceptibility. The analysis 
that follows quantifies the total burden of disease attributable 
to STIs in South Africa, without attempting to frame this in 
terms of a particular definition of ‘unsafe sex’. The analysis 
therefore differs from the conventional approach to attributing 
disease burden to other risk behaviours, which are typically 
more clearly defined characteristics.
In addition to quantifying the STI burden of disease in 
South Africa, this article provides a qualitative assessment 
of the social, behavioural and biological factors responsible 
for the high STI prevalence in South Africa. Past successes 
in STI prevention and treatment are briefly outlined, and 
recommendations for future prevention and treatment 
initiatives are made.
Estimation of the burden of disease 
due to STIs
For the purposes of this analysis, the burden of disease due to 
STIs has been split into two components, namely the burden 
due to HIV/AIDS, and the burden due to other STIs. The 
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Objectives. To estimate the burden of disease attributable 
to sexually transmitted infections (STIs) in South Africa, to 
identify the factors contributing to this burden, and to review 
successes and failures in reducing this burden.
Design. Years of life lost (YLL) and years lived with disability 
(YLD) were estimated using different approaches for HIV/
AIDS, other STIs and cervical cancer. Burden in respect of HIV/
AIDS was estimated using the ASSA2002 model, and for the 
other diseases the revised national burden of disease estimates 
for 2000 based on 1996 cause-of-death data were used. The 
ASSA2002 model was used to estimate numbers of AIDS deaths 
under different prevention and treatment scenarios.
Setting. South Africa.
Outcome measures. Deaths, YLL and disability-adjusted life years 
(DALYs) associated with HIV/AIDS, other STIs and cervical 
cancer. 
Results. STIs accounted for more than 26% of all deaths and 
over 5 million DALYs in 2000 and over 98% of this burden was 
due to HIV/AIDS. A combination of social, behavioural and 
biological conditions contribute to this burden. HIV/AIDS 
mortality and morbidity are estimated to have increased 
significantly since 2000, and the future change in this burden 
is largely dependent on the extent to which antiretroviral 
treatment and HIV prevention programmes are introduced. 2.5 
million AIDS deaths could be prevented by 2015 if high levels 
of access to antiretroviral treatment are achieved. 
Conclusion. South Africa faces one of the largest STI epidemics 
in the world. A multifaceted strategy to prevent and treat STIs 
is needed, and burden of disease assessments should look 
beyond the role of ‘unsafe sex’ when attributing this disease 
burden to risk factors.
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burden due to HIV/AIDS in 2000 was 
determined using the ASSA2002 AIDS 
and Demographic model, a spreadsheet 
model of the South African HIV/AIDS 
epidemic, developed by the Actuarial 
Society of South Africa.6 The model is 
calibrated to the data collected in the 
antenatal prevalence surveys as well 
as death notification data and HIV 
prevalence estimates from household 
surveys. For other STIs (syphilis, 
gonorrhoea, chlamydia and cervical 
cancer), years of life lost (YLLs) were 
estimated based on the 1996 cause-
of-death data, adjusted for under-
registration and mis-classification of 
causes, and years lived with disability 
(YLDs) were estimated by assuming that 
the ratio of YLDs to YLLs is the same 
as that estimated by the WHO for all 
countries in the AFR-E region, for each 
STI.3  
The results are shown in Table I. 
The total disability-adjusted life years 
(DALYs) attributable to STI in 2000 is 
estimated at over 5 million. Of this, 98% 
is due to HIV/AIDS. For HIV/AIDS and 
cervical cancer, most of the burden is 
made up of YLLs, while for other STIs, 
the YLD component exceeds the YLL 
component. The burden due to STIs in 
women is more than 20% greater than 
that in men, partly because of the higher 
STI prevalence in women and partly 
because of the greater number of women 
in the adult population. 
Factors promoting the 
spread of HIV and other 
STIs in South Africa
The high prevalence of STIs in South 
Africa is to a significant extent the 
legacy of the country’s political and 
economic history. The migrant labour 
system has contributed considerably 
to the disruption of stable sexual 
partnerships,7,8 and high levels of 
migration persist, with associated high 
levels of vulnerability to STIs. The 
problem was compounded in the past 
by poor access to STI treatment and poor 
quality of STI treatment in previously 
disadvantaged groups. South Africa has a high 
level of urbanisation compared with other 
African countries, and this has been shown 
to be strongly positively correlated with HIV 
prevalence.9 South Africa’s relatively well-
developed transport infrastructure may also 
have contributed to the rapid geographical 
spread of the HIV/AIDS epidemic.
The low socio-economic status of women 
has also played an important role in the 
spread of STIs and is a continuing obstacle 
to STI prevention efforts. Women are often 
economically dependent on men, and a 
significant proportion of women engage in 
‘transactional sex’.10 Women often report 
not being able to insist on condom use or to 
refuse sex due to fear of partner violence or 
curtailment of material support.11-13 Socio-
economic pressures on young women to find 
financially secure partners also frequently lead 
to partnerships with men significantly older 
than they are.14 In addition, low socio-economic 
standing is a barrier to women disclosing their 
STI status to their partners. African studies 
show that a high proportion of women do not 
inform their partners if they test HIV-positive, 
because of fear of violence or abandonment,15 
and South African studies suggest that 
individuals rarely inform their partners after 
receiving treatment for other STIs.16 
Coupled with the high prevalence of 
transactional sex is the high rate of partner 
concurrency in South Africa. Surveys of 
sexually active youth have found that around 
one-quarter of youth currently in relationships 
have more than one partner,17,18 and this is 
thought to be a significant factor promoting the 
spread of HIV and other STIs.19 Use of alcohol 
also appears to be a risk factor for STIs, with 
heavy drinkers reporting higher numbers of 
partners, greater experience of STIs and greater 
experience of condom failure.20
A large number of biological factors have 
been implicated in the transmission of HIV 
and other STIs. Most importantly: (i) men 
who are uncircumcised face a higher risk of 
infection with HIV, syphilis, chancroid and 
gonorrhoea;21,22 (ii) the high prevalence of 
cervical ectopy in young women has been 
shown to increase susceptibility to HIV and 
chlamydia;23,24 (iii) bacterial STIs generally 
increase susceptibility to HIV, as do other STIs 
such as trichomoniasis and herpes simplex 
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virus type 2 (HSV-2);25 and (iv) bacterial vaginosis appears to be 
associated with the transmission of HIV and other STIs.25-27
Many of these co-factors for STI transmission are common 
in South Africa. For example, roughly 65% of adult men 
in South Africa are uncircumcised,18 and the prevalence of 
bacterial vaginosis in pregnant women is typically between 
25% and 50%.2 Bacterial STIs are common, and HSV-2 and 
trichomoniasis are even more highly prevalent. Behavioural 
factors may compound the effect of biological factors; for 
example, the effect of the high prevalence of cervical ectopy at 
young ages could be particularly pronounced if sexual debut is 
relatively early.
Interventions and behaviour change
Significant STI prevention programmes have been introduced 
in South Africa over the past decade. Since 1994, syndromic 
management protocols for STI treatment have been introduced 
in public health facilities. This may partly explain the dramatic 
decline in the prevalence of syphilis measured at antenatal 
clinics, from 11% in 1997 to 3% in 2005.28 However, syndromic 
management protocols have not been adopted with equal 
enthusiasm by private practitioners, who are estimated to treat 
roughly half of all STI cases.29 In some public STI clinics, drug 
shortages and heavy patient loads limit capacity to implement 
syndromic management protocols.30 Evidence of changes in 
the prevalence of STIs other than syphilis and HIV is generally 
lacking, and there is a need for more periodic cross-sectional 
studies in sentinel populations, that can be used to monitor 
prevalence trends.2
Other prevention programmes have emphasised the need 
for behaviour change. Social marketing programmes such as 
Khomanani and loveLife have been complemented by steady 
increases in condom distribution by the Department of Health 
over recent years.31 Voluntary counselling and testing (VCT) 
has also been heavily promoted, and it is estimated that by 
2003, 70% of public primary health care facilities offered VCT 
services.32 These social marketing and VCT programmes 
appear to have had some impact on sexual behaviour. For 
example, rates of condom usage at last sex, reported by women 
aged 15 - 49, have increased from 8% in 199833 to 29% in 2002.18 
However, there is no evidence of delay in sexual debut, and it 
is unclear whether numbers of partners are declining.34
Success in introducing STI screening programmes has 
been variable. Although public antenatal clinics have been 
conducting antenatal screening for syphilis for a number 
of decades, these programmes continue to experience 
difficulties in terms of lengthy delays between drawing of 
blood and return of test results, women presenting too late 
in pregnancy to receive the full course of syphilis treatment, 
and women not going to the clinics to which they are referred 
for treatment,35-37 with these problems being particularly 
significant in rural areas. Programmes for the prevention 
of mother-to-child transmission (PMTCT) of HIV have also 
been introduced in the public health sector since 2001. These 
appear to have been successful in the Western Cape, but have 
not achieved significant reductions in vertical transmission in 
less well-resourced settings.38 South Africa is one of the few 
developing countries to have a public cervical cancer screening 
programme, but access to this programme remains poor in 
rural areas, and utilisation of screening services has been 
low due to the common misconception that this screening is 
diagnostic rather than preventive.39
Before 2004 treatment for HIV/AIDS was limited mainly to 
the private health sector. In 2003, however, the Department of 
Health announced a comprehensive plan for the treatment of 
HIV/AIDS, including highly active antiretroviral treatment 
(HAART).40 By June of 2006, approximately 180 000 individuals 
had started receiving HAART through the public health 
sector,41 although access to HAART in the public health sector 
remains variable between South Africa’s provinces. Obstacles 
to the rollout of this intervention have included lack of clarity 
regarding the accreditation process for clinics wanting to 
provide HAART, lack of trained personnel and lack of continuity 
of drug supply in some provinces. Access to other forms of HIV 
treatment and prophylaxis is also limited in many areas. 
Effects of prevention and treatment 
programmes
The effect of HIV/AIDS prevention and treatment programmes 
in South Africa is demonstrated by the ASSA2002 AIDS and 
Demographic Model.6 Fig. 1 shows the projected annual 
numbers of AIDS deaths in South Africa in four different 
scenarios: (i) a ‘no intervention’ scenario, in which no 
prevention or treatment programmes are introduced; (ii) a 
‘prevention only’ scenario, allowing for the introduction of 
VCT, social marketing, PMTCT of HIV and improved STI 
treatment at the rates of phase-in achieved in South Africa; 
(iii) a ‘constrained’ scenario, the same as the ‘prevention only’ 
scenario but also including allowance for HAART, which 
is assumed to reach a maximum of 50% of newly eligible 
individuals by 2008; and (iv) an ‘optimistic’ scenario, the same 
as the ‘constrained’ scenario but assuming HAART reaches a 
maximum of 90% of newly eligible individuals by 2008.
1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
AIDS deaths
No intervention 2.610408 15.73629 53.24723 147.1559 369.6298 867.8431 1926.394 4039.247 7979.118 14873.06 26196.61 43323.69 67483.42 99756.9 140573.9 189503.4 245117.4 304894.5 365332.1 422653.9 473623.8 515949 548467.4
Prevention o ly 2.610408 15.73629 53.24723 147.1559 369.6298 867.8431 1926.394 4039.247 7979.118 14857.6 26070.81 42816.62 66064.79 96604.12 134605.1 179214.9 228069.7 278147.7 327071 372562.6 412573.1 445637.4 470489
Constrained 2.610408 15.73629 53.24723 147.1559 369.6298 867.8431 1926.394 4039.247 7979.118 14857.6 26070.81 42816.62 66064.79 96604.12 134196.6 177267.5 223278.4 269442.8 311143 342924 363702.3 375023.3 378303.5
Optimistic 2.610408 15.73629 53.24723 147.1559 369.6298 867.8431 1926.394 4039.247 7979.118 14857.6 26070.81 42816.62 66064.79 96604.12 134196.6 177267.5 223278.4 269442.8 308444.1 330236.3 334041.1 325293 307954
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
1
9
9
5
1
9
9
7
1
9
9
9
2
0
0
1
2
0
0
3
2
0
0
5
2
0
0
7
2
0
0
9
2
0
1
1
2
0
1
3
2
0
1
5
Years
A
n
n
u
a
l 
n
u
m
b
e
r 
o
f 
d
e
a
th
s
No intervention
Prevention only
Constrained
Optimistic
Fig. 1. Annual numbers of AIDS deaths in South Africa.
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The results of the model suggest that prevention and 
treatment programmes have had a significant impact on 
AIDS mortality in South Africa and will continue to have a 
significant impact in future. By 2015, the projected annual 
number of AIDS deaths in the ‘prevention only’ scenario is 18% 
below the level that would be expected in the ‘no intervention’ 
scenario, and the number in the ‘optimistic’ scenario is 41% 
below the ‘no intervention’ scenario estimate. The cumulative 
number of AIDS deaths between 1995 and 2015 is reduced by 
930 000 in the ‘prevention only scenario’ and by 2 500 000 in the 
‘optimistic’ scenario, when compared with the ‘no intervention’ 
scenario.
Discussion
This analysis demonstrates that STIs are contributing 
significantly to the burden of disease in South Africa, 
accounting for almost one-third of the overall burden. Ninety-
eight per cent of this burden of disease was due to HIV/AIDS 
in 2000, and Fig. 1 demonstrates that the HIV/AIDS burden 
has increased substantially since then. The change in the 
HIV/AIDS burden over the next decade will depend largely 
on the extent to which HAART and HIV prevention strategies 
are introduced in South Africa, and it is encouraging that the 
new HIV and AIDS and STI Strategic Plan42 aims to provide 
HAART to 80% of people progressing to AIDS by 2011. 
Changes in the burden due to other STIs are difficult to predict 
owing to the lack of STI studies conducted periodically in the 
same population.
The quantitative analysis has a number of limitations. The 
extent of the HIV/AIDS epidemic, which accounts for most 
of the STI disease burden, is uncertain. In a recent Bayesian 
analysis of HIV prevalence data and vital registration data 
in South Africa,43 it was estimated that the 95% prediction 
interval around the number of AIDS deaths in 2000 was 117 000 
- 185 000. In assessing uncertainty around these estimates, it 
should also be recognised that the YLDs in respect of HIV/
AIDS are very sensitive to the disability weights chosen. In an 
earlier assessment,44 for example, YLD rates varied between 2.3 
and 6.0 per 1 000 when different disability weights were used. 
A further limitation of this analysis is that it does not 
include the burden of disease due to trichomoniasis, HSV-2 
and sexually transmitted hepatitis B. Other assessments4,45 
have shown that these infections contribute significantly to 
the burden of disease, although in this context their effect is 
likely to be small relative to HIV/AIDS. This analysis also 
does not split the STI disease burden according to the mode 
of transmission. In South Africa there is little information 
on the contribution of unsafe injections and transfusions to 
STI transmission, although the contribution is believed to be 
small.46 Paediatric HIV infection is almost all due to mother-
to-child transmission, as shown in a recent study of HIV-
infected South African children,47  99% of whom were found to 
have HIV-positive mothers. In adults, almost all HIV and STI 
transmission is sexual. Transmission of HPV is also thought to 
be almost exclusively sexual, and this virus has been shown to 
account for more than 99% of cervical cancer cases.48 
The review of the factors driving the STI epidemic in South 
Africa demonstrates that there is a host of political, economic, 
social, behavioural and biomedical factors influencing the STI 
epidemic. Because of this complexity, it is neither accurate 
nor helpful to describe the STI burden as being due solely to 
‘unsafe sex’. To succeed in reducing the STI burden it will be 
necessary to adopt a multifaceted strategy that aims to change 
more than just sexual behaviour. The new HIV and AIDS and 
STI Strategic Plan42 recognises the need for such a multifaceted 
approach. 
As a first step, information and education campaigns need 
to accommodate a broader range of messages. Social marketing 
programmes have to date been successful in increasing 
condom usage, but other forms of behaviour change have not 
been observed34 and might therefore need to be promoted in 
a different manner. More emphasis should be placed on STI 
education, with more education on the recognition of STI 
symptoms, the need for prompt treatment and the need for 
partner notification. There is also a need for promotion of 
regular screening for cervical cancer precursors, with emphasis 
on the preventive benefit of this screening.
There is also room for improvement in HIV and STI 
treatment. Training of general practitioners in syndromic 
management protocols and providing access to cheaper STI 
treatment may bring about improvements in the quality of STI 
treatment in the private health sector.29 In the public health 
sector, improving access to HIV treatment is a significant 
challenge. To expand access to HAART in future it will be 
necessary to invest more in the public health infrastructure and 
in recruiting and retaining doctors and nurses in this health 
sector.
The socio-economic environment should also be considered 
in designing HIV prevention strategies. For example, it has 
been suggested that economic empowerment projects targeting 
young women would reduce their economic reliance on men, 
and thus curb HIV incidence in young women.14 Employers 
should also be discouraged from following recruitment 
and deployment practices that promote migration and long 
absences from home.49 
Lastly, advances in biotechnology have the potential to 
reduce the STI burden in South Africa in the long term. 
Microbicides may be effective in preventing the transmission 
of HIV and other STIs, but it is likely to be a number of years 
before an effective microbicide is commercially available.50 
There is an urgent need for vaccines that are effective against 
the main viral STIs: HIV, HSV-2 and HPV. Encouragingly, 
vaccines effective against HPV types 16 and 18 have been 
developed recently,51 and could have a significant impact in 
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South Africa, where HPV types 16 and 18 account for the 
majority of cervical cancer cases.52
We would like to express our sincere thanks to our colleagues 
from the Burden of Disease Research Unit, South African Medical 
Research Council, in particular Rosana Norman for her leadership 
role in the South African Comparative Risk Assessment Project. 
We also acknowledge the guidance of Theo Vos and sincerely 
thank Najma Shaik for reviewing this article and providing critical 
comments and insights. We thank Elize de Kock and Karin Barnard 
for administrative support.
References
  1.  Dorrington RE, Johnson LF, Bradshaw D, Daniel T. The Demographic Impact of HIV/AIDS 
in South Africa. National and Provincial Indicators for 2006. Cape Town: Centre for Actuarial 
Research, South African Medical Research Council and Actuarial Society of South Africa, 
2006. 
  2.  Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted 
infections in South Africa: a review. Sex Transm Infect 2005; 81: 287-293.
  3.  Norman R, Bradshaw D, Schneider M, Pieterse D, Groenewald P. Revised Burden of Disease 
Estimates for the Comparative Risk Factor Assessment. South Africa 2000. Methodological Notes. 
Cape Town: Medical Research Council, 2006.  http://www.mrc.ac.za/bod/bod.htm (last 
accessed 7 July 2006). 
  4.  Berkley S. Unsafe sex as a risk factor. In: Murray CJL, Lopez AD, eds. Health Dimensions of 
Sex and Reproduction. Boston: Harvard University Press, 1998.
  5.  Slaymaker E, Walker N, Zaba B, Collumbien M. Unsafe sex . In: Ezzati M, Lopez 
AD, Rodgers A, Murray CJL, eds. Comparative Quantification of Heath Risks: Global and 
Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health 
Organization, 2004.
  6.  Johnson LF, Dorrington RE. Modelling the demographic impact of HIV/AIDS in South 
Africa and the likely impact of interventions. Demographic Research 2006; 14: 541-574.
  7.  Kark SL. The social pathology of syphilis in Africans. S Afr Med J 1949; 23: 77-84.
  8.  Lurie M. Migration and AIDS in southern Africa: a review. South African Journal of Science 
2000; 96: 343-347.
  9.  Dyson T. HIV/AIDS and urbanization. Population and Development Review 2003; 29: 427-442.
10.  Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Transactional sex 
among women in Soweto, South Africa: prevalence, risk factors and association with HIV 
infection. Soc Sci Med 2004; 59: 1581-1592.
11.  MacPhail C, Campbell C. ‘I think condoms are good but, aai, I hate those things’: condom 
use among adolescents and young people in a Southern African township. Soc Sci Med 2001; 
52: 1613-1627.
12.  Jewkes R, Vundule C, Maforah F, Jordaan E. Relationship dynamics and teenage pregnancy 
in South Africa. Soc Sci Med 2001; 52: 733-744.
13.  Varga CA. The condom conundrum: barriers to condom use among commercial sex workers 
in Durban, South Africa. Afr J Reprod Health 1997; 1(1): 74-88.
14.  Gregson S, Nyamukapa CA, Garnett GP, et al. Sexual mixing patterns and sex-differentials in 
teenage exposure to HIV infection in rural Zimbabwe. Lancet 2002; 359: 1896-1903.
15.  Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV 
serostatus disclosure among women in developing countries: implications for prevention of 
mother-to-child transmission programmes. Bull World Health Organ 2004; 82: 299-307.
16.  Mathews C, Guttmacher SJ, Coetzee N, et al. Evaluation of a video based health education 
strategy to improve sexually transmitted disease partner notification in South Africa. Sex 
Transm Infect 2002; 78(1): 53-57.
17.  Auvert B, Ballard R, Campbell C, et al. HIV infection in a South African mining town is 
associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 2001; 15: 
885-898.
18.  Shisana O, Simbayi LC. South African National HIV Prevalence, Behavioural Risks and Mass 
Media Household Survey 2002. Cape Town: Human Sciences Research Council Press, 2002. 
19.  Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997; 11: 
641-648.
20.  Simbayi LC, Kalichman SC, Jooste S, Mathiti V, Cain D, Cherry C. Alcohol use and sexual 
risks for HIV infection among men and women receiving sexually transmitted infection clinic 
services in Cape Town, South Africa. J Stud Alcohol 2004; 65: 434-442.
21.  Moses S, Bailey RC, Ronald AR. Male circumcision: assessment of health benefits and risks. 
Sex Transm Infect 1998; 74: 368-373.
22.  Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, 
chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 2006; 
82: 101-109.
23.  Jacobson DL, Peralta L, Farmer M, Graham NM, Gaydos C, Zenilman J. Relationship of 
hormonal contraception and cervical ectopy as measured by computerized planimetry to 
chlamydial infection in adolescents. Sex Transm Dis 2000; 27: 313-319.
24.  Moss GB, Clemetson D, D’Costa L, et al. Association of cervical ectopy with heterosexual 
transmission of human immunodeficiency virus: results of a study of couples in Nairobi, 
Kenya. J Infect Dis 1991; 164: 588-591.
25.  Røttingen J, Cameron DW, Garnett GP. A systematic review of the epidemiological 
interactions between classic sexually transmitted diseases and HIV: how much is really 
known? Sex Transm Dis 2001; 28: 579-597.
26.  Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of 
human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect 
Dis 1999; 180: 1863-1868.
27.  Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL. Genital tract shedding 
of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial 
vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005; 40: 1422-1428.
28.  Department of Health. National HIV and Syphilis Prevalence Survey, South Africa 2005. Pretoria: 
Directorate of Epidemiology and Surveillance, DOH, 2006.
29.  Schneider H, Blaauw D, Dartnall E, Coetzee DJ, Ballard RC. STD care in the South African 
private health sector. S Afr Med J 2001; 91: 151-156.
30.  Sonko R, McCoy D, Gosa E, et al. Sexually transmitted infections. In: Ijumba P, Ntuli A, 
Barron P, eds. South African Health Review 2002. Durban: Health Systems Trust, 2003.
31.  Myer L. Barrier methods. In: Abdool Karim SS, Abdool Karim Q, eds. HIV/AIDS in South 
Africa. Cape Town: Cambridge University Press, 2005.
32.  Reagon G, Irlam J, Levin J. The National Primary Health Care Facilities Survey 2003. Durban: 
Health Systems Trust, 2004. 
33.  Department of Health. South African Demographic and Health Survey 1998. Full Report. 
Pretoria: DOH, 2001.
34.  Bradshaw D, Pettifor A, MacPhail C, Dorrington RE. Trends in youth risk for HIV. In: Ijumba 
P, Day C, Ntuli A, eds. South African Health Review 2003. Durban: Health Systems Trust, 2004.
35.  Fonn S. A blood-result turn-around time survey to improve congenital syphilis prevention in 
a rural area. S Afr Med J 1996; 86(1): 67-71.
36.  Swingler GH, van Coeverden de Groot HA. The antenatal prevention of congenital syphilis 
in a peri-urban settlement. S Afr Med J 1993; 83: 34-35.
37.  Myer L, Wilkinson D, Lombard C, Zuma K, Rotchford K, Abdool Karim SS. Impact of on-site 
testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in 
rural South Africa: a randomised control trial. Sex Transm Infect 2003; 79: 208-213.
38.  Jackson DJ, Chopra M, Doherty TM, et al. Operational effectiveness and 36 week HIV-free 
survival in the South African programme to prevent mother-to-child transmission of HIV-1. 
AIDS 2007; 21: 509-516.
39.  Wood K, Jewkes R, Abrahams N. Cleaning the womb: constructions of cervical screening and 
womb cancer among rural black women in South Africa. Soc Sci Med 1997; 45: 283-294.
40.  Department of Health. Operational Plan for Comprehensive HIV and AIDS Care, Management and 
Treatment for South Africa. Pretoria: DOH, 2003. 
41.  Department of Health. National Comprehensive HIV and AIDS Plan Statistics; 2006. http://
www.doh.gov.za/docs/statistics-f.html (last accessed 1 December 2006). 
42.  Department of Health. HIV and AIDS and STI Strategic Plan for South Africa, 2007 - 2011. 
Pretoria: DOH, 2007. 
43.  Johnson LF, Dorrington RE, Matthews A. An investigation into the extent of uncertainty 
surrounding estimates of the impact of HIV/AIDS in South Africa. South African Journal of 
Science (in press). 
44.  Nannan N, Johnson L, Bradshaw D. Measuring DALYs due to HIV/AIDS. South African 
AIDS Conference, 3 - 6 August 2003, Durban, South Africa.
45.  Ebrahim SH, McKenna MT, Marks JS. Sexual behaviour: related adverse health burden in the 
United States. Sex Transm Infect 2005; 81: 38-40.
46.  Schmid GP, Buvé A, Mugyenyi P, et al. Transmission of HIV-1 infection in sub-Saharan Africa 
and effect of elimination of unsafe injections. Lancet 2004; 363: 482-488.
47.  Shisana O, Mehtar S, Mosala T, et al. HIV Risk Exposure Among Young Children: A Study of 2-9 
Year Olds Served by Public Health Facilities in the Free State, South Africa. Cape Town: Human 
Sciences Research Council, 2005. 
48.  Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of 
invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12-19.
49.  Shisana O, Peltzer K, Zungu-Dirwayi N, Louw J. The Health of our Educators: A Focus on HIV/
AIDS in South African Public Schools. Cape Town: Human Sciences Research Council, 2005. 
50.  Weber J, Desai K, Darbyshire J. The development of vaginal microbicides for the prevention 
of HIV transmission. PLoS Med 2005; 2: e142.
51.  Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 
6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind 
placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 271-278.
52.  Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 
16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J 
Med Virol 2003; 71: 265-273.
sexually transmitted.indd   662 7/31/07   5:12:44 PM
